UVRAG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.21550000004223E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.26729999999831E-06 |
Normal-vs-Stage2 |
1.075850E-01 |
Normal-vs-Stage3 |
3.51450000000142E-05 |
Normal-vs-Stage4 |
3.999600E-04 |
Stage1-vs-Stage2 |
2.295200E-01 |
Stage1-vs-Stage3 |
4.658400E-01 |
Stage1-vs-Stage4 |
4.590800E-01 |
Stage2-vs-Stage3 |
8.270000E-02 |
Stage2-vs-Stage4 |
1.167630E-01 |
Stage3-vs-Stage4 |
6.676000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.1058999995266E-07 |
Normal-vs-AfricanAmerican |
2.766100E-02 |
Normal-vs-Asian |
9.557300E-03 |
Caucasian-vs-AfricanAmerican |
7.141700E-02 |
Caucasian-vs-Asian |
8.474200E-01 |
AfricanAmerican-vs-Asian |
4.686200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.17579999964401E-07 |
Normal-vs-Female |
3.411900E-02 |
Male-vs-Female |
3.304300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.062000E-03 |
Normal-vs-Extreme_Weight |
6.7997999997349E-07 |
Normal-vs-Obese |
2.664000E-03 |
Normal-vs-Extreme_Obese |
2.576200E-04 |
Normal_Weight-vs-Extreme_Weight |
3.837200E-01 |
Normal_Weight-vs-Obese |
7.312000E-01 |
Normal_Weight-vs-Extreme_Obese |
3.775600E-01 |
Extreme_Weight-vs-Obese |
1.706760E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.278000E-01 |
Obese-vs-Extreme_Obese |
2.809200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.438950E-01 |
Normal-vs-Age(41-60Yrs) |
7.588200E-04 |
Normal-vs-Age(61-80Yrs) |
3.97310000010975E-07 |
Normal-vs-Age(81-100Yrs) |
1.024360E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.128200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.068200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.646200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.993700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.383200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.909000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.61878999999088E-05 |
Normal-VS-Type2 PRCC |
1.80330000043583E-07 |
Normal-VS-KIRP CIMP |
3.295800E-01 |
Normal-VS-Unclassified PRCC |
1.162850E-01 |
Type1 PRCC-VS-Type2 PRCC |
9.055700E-02 |
Type1 PRCC-VS-KIRP CIMP |
3.670800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.967200E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.075790E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.897800E-02 |
KIRP CIMP-VS-Unclassified PRCC |
9.314800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.83510000037768E-07 |
Normal-vs-N1 |
1.560470E-02 |
Normal-vs-N2 |
1.202440E-02 |
N0-vs-N1 |
2.420200E-01 |
N0-vs-N2 |
9.408800E-01 |
N1-vs-N2 |
5.823400E-01 |
|
|